Stockreport

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

FibroBiologics, Inc.  (FBLG) 
PDF HOUSTON, March 19, 2024 /PRNewswire/ -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pend [Read more]